ArticleInternational journal of molecular sciences2026
Circulating METRNL, Adipocytokines, and Insulin-Resistance Markers After Repeated Whole-Body Cryotherapy in Women of Different Ages.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Metabolic risk increases with age and may be accompanied by changes in adipocytokine secretion and insulin sensitivity. The primary exploratory aim of this prospective, uncon-trolled study was to determine whether repeated whole-body cryotherapy (WBC) changes circulating meteorin-like hormone (METRNL) concentrations in women of different ages. Secondary exploratory outcomes included irisin, asprosin, leptin, adiponectin, insulin, fasting blood glucose (FBG), lipid profile, homeostasis model assessment of insulin resistance (HOMA-IR), triglyceride-glucose index (TyG), atherogenic index of plasma (AIP), and the leptin/adiponectin ratio. A total of 48 women were divided into three groups: GR-60 (60-70 years, n = 14), GR-40 (40-50 years, n = 18), and GR-20 (20-30 years, n = 16). Participants underwent 30 WBC sessions, each lasting 3 min at minus 120 °C. Blood samples were collected before the first WBC session, after the 10th, 20th, and 30th sessions, and two weeks after the final session. Repeated WBC did not significantly change circulating METRNL or other adipocytokines in any age group. A preliminary decrease in insulin concentration and HOMA-IR was observed after 20 WBC sessions only in GR-60. These findings suggest that repeated WBC may be associated with favorable changes in selected insulin-resistance markers in older postmenopausal women; however, the absence of a non-WBC control group, small subgroup sizes, and the multiplicity burden preclude causal or therapeutic conclusions. Randomized controlled studies are needed to verify these exploratory observations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.